EPIX NASDAQ
ESSA Pharma Inc.
1W: -7.5%
1M: -1.9%
3M: -5.0%
1Y: -73.6%
3Y: -9.2%
5Y: -75.2%
$0.20
Last traded 2025-10-09 — delisted
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$0
+0.0% ▲
Gross Profit
-$91K
+23.5% ▲
Operating Income
-$34M
-7.1% ▼
Net Income
-$29M
-7.4% ▼
EPS (Diluted)
$-0.64
-6.7% ▼
EBITDA
-$28M
-7.5% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% |
| Cost of Revenue | $110K | $109K | $122K | $118K | $91K |
| Gross Profit | -$110K | -$109K | -$122K | -$118K | -$91K |
| Gross Margin | — | — | — | — | — |
| R&D Expenses | $12M | $24M | $24M | $21M | $21M |
| SG&A Expenses | $11M | $13M | $13M | $11M | $13M |
| Operating Expenses | $24M | $37M | $37M | $32M | $34M |
| Operating Income | -$23M | -$37M | -$35M | -$32M | -$34M |
| Operating Margin | — | — | — | — | — |
| Interest Expense | $618K | $22K | $14K | $7K | $0 |
| Income Before Tax | -$24M | -$37M | -$35M | -$27M | -$29M |
| Tax Expense | -$289K | -$34K | -$112K | $2K | $0 |
| Net Income | -$23M | -$37M | -$35M | -$27M | -$29M |
| Net Margin | — | — | — | — | — |
| EPS (Diluted) | $-1.04 | $-0.96 | $-0.80 | $-0.60 | $-0.64 |
| EBITDA | -$23M | -$37M | -$35M | -$26M | -$28M |
| Shares Outstanding | 22M | 38M | 44M | 44M | 44M |